Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 75919-68-5
2. Refchem:1081378
3. Benzoic Acid, 4-hydroxy-, Butyl Ester, Mixt. With 1-hexadecanol, Methyl 4-hydroxybenzoate, 1-octadecanol, 1,2-propanediol, Propyl 4-hydroxybenzoate And Sodium Dodecyl Sulfate
| Molecular Weight | 1404.0 g/mol |
|---|---|
| Molecular Formula | C78H139NaO17S |
| Hydrogen Bond Donor Count | 7 |
| Hydrogen Bond Acceptor Count | 17 |
| Rotatable Bond Count | 54 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 295 |
| Heavy Atom Count | 97 |
| Formal Charge | 0 |
| Complexity | 1000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 8 |
ABOUT THIS PAGE
22
PharmaCompass offers a list of Cetaphil API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cetaphil manufacturer or Cetaphil supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cetaphil manufacturer or Cetaphil supplier.
A Cetaphil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cetaphil, including repackagers and relabelers. The FDA regulates Cetaphil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cetaphil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cetaphil supplier is an individual or a company that provides Cetaphil active pharmaceutical ingredient (API) or Cetaphil finished formulations upon request. The Cetaphil suppliers may include Cetaphil API manufacturers, exporters, distributors and traders.
Cetaphil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cetaphil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cetaphil GMP manufacturer or Cetaphil GMP API supplier for your needs.
A Cetaphil CoA (Certificate of Analysis) is a formal document that attests to Cetaphil's compliance with Cetaphil specifications and serves as a tool for batch-level quality control.
Cetaphil CoA mostly includes findings from lab analyses of a specific batch. For each Cetaphil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cetaphil may be tested according to a variety of international standards, such as European Pharmacopoeia (Cetaphil EP), Cetaphil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cetaphil USP).
